Self-Organizing 3D Human Trunk Neuromuscular Organoids.

NMOs NMPs central pattern generators myasthenia gravis neuromesodermal progenitors neuromuscular diseases neuromuscular junction neuromuscular organoids skeletal muscles spinal cord

Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
06 02 2020
Historique:
received: 18 03 2019
revised: 30 09 2019
accepted: 16 12 2019
pubmed: 21 1 2020
medline: 28 4 2021
entrez: 21 1 2020
Statut: ppublish

Résumé

Neuromuscular networks assemble during early human embryonic development and are essential for the control of body movement. Previous neuromuscular junction modeling efforts using human pluripotent stem cells (hPSCs) generated either spinal cord neurons or skeletal muscles in monolayer culture. Here, we use hPSC-derived axial stem cells, the building blocks of the posterior body, to simultaneously generate spinal cord neurons and skeletal muscle cells that self-organize to generate human neuromuscular organoids (NMOs) that can be maintained in 3D for several months. Single-cell RNA-sequencing of individual organoids revealed reproducibility across experiments and enabled the tracking of the neural and mesodermal differentiation trajectories as organoids developed and matured. NMOs contain functional neuromuscular junctions supported by terminal Schwann cells. They contract and develop central pattern generator-like neuronal circuits. Finally, we successfully use NMOs to recapitulate key aspects of myasthenia gravis pathology, thus highlighting the significant potential of NMOs for modeling neuromuscular diseases in the future.

Identifiants

pubmed: 31956040
pii: S1934-5909(19)30525-9
doi: 10.1016/j.stem.2019.12.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

172-186.e6

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Jorge-Miguel Faustino Martins (JM)

Stem Cell Modelling of Development & Disease Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Cornelius Fischer (C)

Scientific Genomics Platforms, Laboratory of Functional Genomics, Nutrigenomics and Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Alessia Urzi (A)

Stem Cell Modelling of Development & Disease Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Ramon Vidal (R)

Scientific Genomics Platforms, Laboratory of Functional Genomics, Nutrigenomics and Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Severine Kunz (S)

Electron Microscopy Core Facility, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Pierre-Louis Ruffault (PL)

Developmental Biology and Signal Transduction Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Loreen Kabuss (L)

Stem Cell Modelling of Development & Disease Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Iris Hube (I)

Stem Cell Modelling of Development & Disease Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Elisabeta Gazzerro (E)

Muscle Research Unit, Experimental and Clinical Research Center (ECRC), Charité Medical Faculty, and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Carmen Birchmeier (C)

Developmental Biology and Signal Transduction Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Simone Spuler (S)

Muscle Research Unit, Experimental and Clinical Research Center (ECRC), Charité Medical Faculty, and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Sascha Sauer (S)

Scientific Genomics Platforms, Laboratory of Functional Genomics, Nutrigenomics and Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Mina Gouti (M)

Stem Cell Modelling of Development & Disease Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany. Electronic address: mina.gouti@mdc-berlin.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH